APLM
Apollomics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.50
−1.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -24.98x
- Price / sales
- 9.15x
- Price / cash flow
- -7.68x
Enterprise value
- Enterprise value
- $77.0M
- EV / sales
- 8.85x
- EV / EBITDA
- -1.52x
- EV / EBIT
- -1.49x
- Market cap
- $79.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025